An NCI-designated Comprehensive Cancer Center

Ravi Salgia, M.D., Ph.D.

Medical Oncologist; Arthur & Rosalie Kaplan Endowed Chair in Medical Oncology
Clinical Expertise
  • Lung cancer
  • Mesothelioma
  • Thymic malignancies
  • Bronchial carcinoids
  • Molecular alterations in thoracic malignancies
  • Thoracic malignancies
Research Focus
  • Lung cancer
  • Mesothelioma
  • Immunotherapy
  • Targeted therapies
  • Prevention of toxicities
  • Drug development
  • Database development
  • Mechanisms of metastases
  • Value-based genomics
Appointments
Professor and Chair, Department of Medical Oncology & Therapeutics Research; Associate Director for Clinical Sciences; Professor and Chair, Department of Medical Oncology & Therapeutics Research; Associate Director for Clinical Sciences
Other Languages Spoken
  • Hindi

Clinical Teams

  • Lung Cancer and Thoracic Oncology

Ravi Salgia M.D., Ph.D., is the Arthur & Rosalie Kaplan Endowed Chair in Medical Oncology and the associate director for clinical sciences at City of Hope's comprehensive cancer center.

Prior to joining City of Hope, Dr. Salgia served as tenured professor of medicine, pathology and dermatology; director of the Thoracic Oncology Program and the Aerodigestive Tract Program Translational Research Lab in the section of hematology/oncology; vice chair for translational research in the department of medicine; and associate director for translational science at the University of Chicago Comprehensive Cancer Center in Chicago.

Dr. Salgia earned his undergraduate summa cum laude in mathematics, biology and chemistry, and then his medical doctorate and Ph.D. from Loyola University in Chicago, where he also completed fellowships in neurochemistry and physiology. He continued his postgraduate training with an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore, followed by a fellowship in medical oncology at Dana-Farber Cancer Institute in Boston, during which time he also served as a clinical fellow at Harvard Medical School in Boston.

Board-certified in medical oncology, Dr. Salgia serves on various panels for the National Cancer Institute. He has consistently received research grants from the National Institutes of Health for his research work, and has been awarded several invention discoveries and patents related to his work. He is the co-chief editor for the Journal of Carcinogenesis. Dr. Salgia also serves on the editorial advisory board of four additional journals. He has authored over 375 peer-reviewed articles, reviews and editorials, one book and over 30 book chapters.

Dr. Salgia is frequently invited to present his work at national and international conferences and symposia, and is the recipient of several honors and awards including πμε National Competition in Mathematics, Richard V. Andree Award for “Volume of an n-Dimensional Unit Sphere”; 2016 Asclepius Award from the Bonnie J. Addario Lung Cancer Foundation; IACA Award for Outstanding Contributions to Oncology; served as member of NIH/NCI’s Tumor Progression and Metastasis Study Section; and CONC Study Section; and he is also a member of the Thoracic Malignancy Steering Committee of the NCI.

Locations

City of Hope Comprehensive Cancer Center, 1500 East Duarte Road

Duarte, CA 91010

In The News
An Expert's Voice
salgia-ravi-300x300

City of Hope's Ravi Salgia Discovers New Biomarker Link in Nonsmall Cell Lung Cancer

Lung Cancer Survivor Story | City of Hope

Advanced Lung Cancer Patient: ‘I’m Not About to Go Quietly into the Night’

City of Hope News

City of Hope physicians, scientists to address notable advancements in liquid biopsy, genomic profiling at ESMO Congress